Lejeune, M.; Reverté, L.; Sauras, E.; Gallardo, N.; Bosch, R.; Roso, A.; Petit, A.; Peg, V.; Riu, F.; García-Fontgivell, J.;
et al. Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers 2023, 15, 597.
https://doi.org/10.3390/cancers15030597
AMA Style
Lejeune M, Reverté L, Sauras E, Gallardo N, Bosch R, Roso A, Petit A, Peg V, Riu F, García-Fontgivell J,
et al. Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers. 2023; 15(3):597.
https://doi.org/10.3390/cancers15030597
Chicago/Turabian Style
Lejeune, Marylène, Laia Reverté, Esther Sauras, Noèlia Gallardo, Ramon Bosch, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell,
and et al. 2023. "Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response" Cancers 15, no. 3: 597.
https://doi.org/10.3390/cancers15030597
APA Style
Lejeune, M., Reverté, L., Sauras, E., Gallardo, N., Bosch, R., Roso, A., Petit, A., Peg, V., Riu, F., García-Fontgivell, J., Ibáñez, J., Relea, F., Vieites, B., Bor, C., de la Cruz-Merino, L., Arenas, M., Rodriguez, V., Galera, J., Korzynska, A.,
... López, C.
(2023). Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers, 15(3), 597.
https://doi.org/10.3390/cancers15030597